Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Eurofins Genomics Buys VBC-Biotech Businesses, Establishes Austrian Subsidiary

By LabMedica International staff writers
Posted on 18 Nov 2014
Eurofins Genomics (Ebersberg, Germany) has acquired VBC-Biotech's (Vienna, Austria) oligonucleotide synthesis and DNA sequencing businesses, and an Austrian subsidiary is being established.

Eurofins MWG Operon is an international provider of genomic services established around the core business lines next generation sequencing (NGS), custom DNA sequencing, oligonucleotides, siRNA, and gene synthesis. More...
A team of experts and a broad range of technologies in the field of genomic services, forensics, agroscience, pharmaceutical, environmental, food and feed testing, underline the approach to offer best praxis solutions and versatile concepts.

Eurofins Genomics is the genomics division of the Eurofins Scientific Group. The Austrian subsidiary called Eurofins Genomics AT and headquartered in Vienna, will leverage Eurofins' global network, production capacity, and infrastructure. "The new direct presence in Austria will provide value to our customers by demonstration our commitment to this market," Eurofins Genomics AT Managing Director Siegfried Schnabl said in a statement. "Furthermore, Vienna will serve as a perfect hub for future business into Central and Eastern Europe and beyond."

The joint company is located in Vienna. All VBC-Biotech's services have been integrated into the Eurofins Genomics business units.

Financial and other terms of the deal were not disclosed.

Related Links:

Eurofins Genomics
VBC-Biotech's



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.